ENTRY       D07445                      Drug
NAME        Amfetamine (INN);
            Amphetamine;
            Amfetamin (TN);
            Adzenys (TN);
            Dyanavel (TN)
PRODUCT     ADZENYS XR-ODT (Neos Therapeutics Brands)
            DYANAVEL XR (NextWave Pharmaceuticals)
            DYANAVEL XR (Tris Pharma)
FORMULA     C9H13N
EXACT_MASS  135.1048
MOL_WEIGHT  135.2062
CLASS       Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Same as: C07514
            ATC code: N06BA01
            Chemical structure group: DG00966
            Product (DG00966): D07445<US> D02074<US>
EFFICACY    Stimulant (central)
  DISEASE   Attention deficit hyperactivity disorder [DS:H01895]
TARGET      SLC18A2 (VMAT2) [HSA:6571] [KO:K08155]
            SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
            SLC6A3 (DAT1) [HSA:6531] [KO:K05036]
  PATHWAY   hsa04721(6530+6531+6571)  Synaptic vesicle cycle
            hsa04726(6571)  Serotonergic synapse
            hsa04728(6531+6571)  Dopaminergic synapse
            hsa05031(6531+6571)  Amphetamine addiction
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07234  Neurotransmitter transporter inhibitors
OTHER_MAP   map05031  Amphetamine addiction
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
                N06BA Centrally acting sympathomimetics
                 N06BA01 Amfetamine
                  D07445  Amfetamine (INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Attention Deficit Hyperactivity Disorder Agents, Amphetamines
               Amphetamine
                D07445  Amfetamine (INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00966  Amfetamine
                D07445  Amfetamine
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D07445  Amfetamine (INN) &lt;US&gt;
                SLC6A3 (DAT1)
                 D07445  Amfetamine (INN) &lt;US&gt;
               SLC18
                SLC18A2 (VMAT2)
                 D07445  Amfetamine (INN) &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07445
            Prodrugs [br08324.html]
             D07445
            Narcotics and psychotropics in Japan [br08308.html]
             Stimulants by Control Act Article 2 Appended Table and Cabinet Order
              D07445
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00966  Amfetamine
DBLINKS     CAS: 300-62-9
            PubChem: 51091776
            ChEBI: 2679
            LigandBox: D07445
            NIKKAJI: J231.296D
ATOM        10
            1   C8y C    18.0426  -15.4812
            2   C8x C    16.8566  -14.7835
            3   C8x C    18.0426  -16.8766
            4   C1b C    19.2287  -14.7835
            5   C8x C    15.6008  -15.4812
            6   C8x C    16.8566  -17.5742
            7   C1c C    20.4845  -15.4812
            8   C8x C    15.6008  -16.8766
            9   N1a N    21.6705  -14.7835
            10  C1a C    20.4845  -16.8766
BOND        10
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 2
            8     7   9 1
            9     7  10 1
            10    6   8 1
///
